ERBB2 and inflammatory breast carcinoma: Transcriptome profiling analyses revealed that IBC is highly heterogeneous, showing the same molecular subtypes of non-IBC, with a higher proportion of HER2-positive and triple-negative (TNBC: negativity for estrogen receptor: ER, progesterone receptor: PR, and HER2) subtypes [2,5,11,12,13].